Access to anti-retroviral drugs, male in Malaysia
Malaysia: Access to anti-retroviral drugs, male was 59.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Malaysia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Malaysia stood at 59.0%. That is the highest value across all 25 years on record.
That represents a change of up 3.5% on the previous year and up 156.5% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Malaysia peaked at 59.0% in 2024 and was at its lowest, 0.0%, in 2000.
Malaysia ranks 105th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Malaysia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 2.0% | — |
| 2002 | 4.0% | +100.0% |
| 2003 | 5.0% | +25.0% |
| 2004 | 7.0% | +40.0% |
| 2005 | 8.0% | +14.3% |
| 2006 | 10.0% | +25.0% |
| 2007 | 11.0% | +10.0% |
| 2008 | 12.0% | +9.1% |
| 2009 | 13.0% | +8.3% |
| 2010 | 15.0% | +15.4% |
| 2011 | 16.0% | +6.7% |
| 2012 | 16.0% | +0.0% |
| 2013 | 18.0% | +12.5% |
| 2014 | 23.0% | +27.8% |
| 2015 | 28.0% | +21.7% |
| 2016 | 40.0% | +42.9% |
| 2017 | 44.0% | +10.0% |
| 2018 | 47.0% | +6.8% |
| 2019 | 50.0% | +6.4% |
| 2020 | 54.0% | +8.0% |
| 2021 | 54.0% | +0.0% |
| 2022 | 54.0% | +0.0% |
| 2023 | 57.0% | +5.6% |
| 2024 | 59.0% | +3.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7.2% | 0.0% | 13.0% | 10 |
| 2010s | 29.7% | 15.0% | 50.0% | 10 |
| 2020s | 55.6% | 54.0% | 59.0% | 5 |
Countries ranked near Malaysia
- 102 Albania 60.0% compare
- 102 Maldives 60.0% compare
- 102 North Macedonia 60.0% compare
- 105 Bolivia, Plurinational State of 59.0% compare
- 105 Syrian Arab Republic 59.0% compare
- 105 Venezuela, Bolivarian Republic of 59.0% compare
More gender data for Malaysia
- Child population (UN estimates and projections) 7,206 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.39 % change on previous year (2030)
- Population 30,756 (2030)
- Working-age population (UN estimates and projections) 30,756 (2030)
- Population (UN estimates and projections), annual growth rate 1.62 % change on previous year (2030)
- Age population, age 00, female, interpolated 214,187 (2025)
- Age population, age 00, male, interpolated 227,793 (2025)
- Age population, age 01, female, interpolated 214,543 (2025)
- Age population, age 01, male, interpolated 228,149 (2025)
- Age population, age 02, female, interpolated 213,108 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Malaysia?
- Access to anti-retroviral drugs, male in Malaysia was 59.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Malaysia?
- The highest recorded value was 59.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Malaysia?
- The lowest recorded value was 0.0% in 2000.
- How does Malaysia rank for access to anti-retroviral drugs, male?
- Malaysia ranks 105th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Malaysia?
- Over the last ten years it is up 156.5%. The long-run trend across the full record is volatile.
- Where does this Malaysia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.